maticspot.blogg.se

Endo 602 vs 349
Endo 602 vs 349










endo 602 vs 349

Dr Baillargeon reported personal fees from AbbVie, Endo Pharmaceuticals, GlaxoSmithKline, and Auxilium Pharmaceuticals outside the submitted work. Īdministrative, technical, or material support: Williams, Hudgins, Jazzar, Swanson, Hu, Mehta.Ĭonflict of Interest Disclosures: Dr Williams reported grants from the US Department of Defense outside the submitted work. Statistical analysis: Shan, Ray-Zack, Baillargeon, Kaul, Mehta.

endo 602 vs 349 endo 602 vs 349

#Endo 602 vs 349 full

doi:10.1001/jamasurg.2019.1629Īuthor Contributions: Dr Williams had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Ĭoncept and design: Williams, Jazzar, Tyler, Swanson, Hu, Kamat, Mehta.Īcquisition, analysis, or interpretation of data: Williams, Shan, Ray-Zack, Hudgins, Jazzar, Freedland, Baillargeon, Kaul, Gore, Mehta.ĭrafting of the manuscript: Williams, Shan, Ray-Zack, Hudgins, Jazzar, Hu, Mehta.Ĭritical revision of the manuscript for important intellectual content: Williams, Ray-Zack, Hudgins, Tyler, Freedland, Swanson, Baillargeon, Kaul, Kamat, Gore, Mehta. Williams, MD, Division of Urology, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555 ( Online: June 5, 2019.












Endo 602 vs 349